Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 13,206Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7GENZYME CORP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2040-10-13

RILZABRUTINIB

US Patent Number : 12178818

Drug Substance Claim :

Drug Product Claim :

Application Number : 219685

Patent Use Code : U-4267

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-10-13

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-09-06

RILZABRUTINIB

US Patent Number : 9994576

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219685

Patent Use Code : U-4268

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-06

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-09-06

RILZABRUTINIB

US Patent Number : 9994576

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219685

Patent Use Code : U-4269

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-06

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-09-06

RILZABRUTINIB

US Patent Number : 9266895

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219685

Patent Use Code : U-4268

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-06

Sanofi Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-09-06

RILZABRUTINIB

US Patent Number : 8940744

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219685

Patent Use Code : U-4270

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-06

Sanofi Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2041-02-20

RILZABRUTINIB

US Patent Number : 11708370

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 219685

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-20

Sanofi Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-03-01

RILZABRUTINIB

US Patent Number : 9580427

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219685

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-01

Sanofi Company Banner